Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2014

View Archived Issues

Ubiquigent and University of Dundee form ubiquitin pathway compound library collaboration

Study finds new genes affected by MS-associated polymorphisms

Blaze Bioscience receives NCI funding for Tumor Paint BLZ-100 in sarcoma

VaxInnate plans study of VAX-2012Q in the elderly to begin by year-end

Promising initial phase I data for pramlintide/insulin fixed-dose combination

New ROR-gamma receptor modulators patented by Roche and Genentech

Vertex patents novel ATR inhibitors for cancer

Novel PDH kinase inhibitors patented at Japan Tobacco

A team of scientists in Taipai designs new polypeptides for C. difficile infection

Easy, safe and accurate local treatment of seborrheic keratosis lesions with BL-5010

Bristol-Myers Squibb reports new KCNA5 blockers

PIQUR plans phase I study of PQR-309 for relapsed or refractory lymphoma

Pathogen-specific PET tracer antibody-based molecular imaging of invasive Aspergillosis

Karolinska Institute awarded Knut and Alice Wallenberg Foundation grant

CytRx begins phase Ib trial evaluating combination of aldoxorubicin and gemcitabine

Novel DPP IV inhibitor discovered for the treatment of type 2 diabetes

Boston Therapeutics reports topline phase IIb data for BTI-320 in type 2 diabetes

Fusion Antibodies and ISCA Diagnostic complete humanization of Aspergillus-specific MAb

Amarantus reports data for Alzheimer's blood diagnostic LymPro Test

Topline results from the first part of a phase I/II trial of necuparanib in pancreatic cancer

ContraFect establishes collaborative research agreement with China CDC for CF-404

FDA approves Velcade for previously untreated mantle cell lymphoma

Capricor plans clinical program for cenderitide for post-acute heart failure

FDA accepts BLA for blinatumomab in acute lymphoblastic leukemia

Xoma initiates phase I trial of insulin receptor inhibitor antibody

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...